These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

94 related articles for article (PubMed ID: 1317483)

  • 1. Anti-neoplastic effects of interleukin-4.
    Redmond HP; Schuchter L; Bartlett D; Kelly CJ; Shou J; Leon P; Daly JM
    J Surg Res; 1992 Apr; 52(4):406-11. PubMed ID: 1317483
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Inhibition of TC-1 cytokine production, effector cytotoxic T lymphocyte development and alloantibody production by 2,3,7,8-tetrachlorodibenzo-p-dioxin.
    Kerkvliet NI; Baecher-Steppan L; Shepherd DM; Oughton JA; Vorderstrasse BA; DeKrey GK
    J Immunol; 1996 Sep; 157(6):2310-9. PubMed ID: 8805628
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Inhibition of tumor-specific cytotoxic T-lymphocyte responses by transforming growth factor beta 1.
    Inge TH; Hoover SK; Susskind BM; Barrett SK; Bear HD
    Cancer Res; 1992 Mar; 52(6):1386-92. PubMed ID: 1531782
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Tumor target-derived soluble factor synergizes with IFN-gamma and IL-2 to activate macrophages for tumor necrosis factor and nitric oxide production to mediate cytotoxicity of the same target.
    Jiang H; Stewart CA; Fast DJ; Leu RW
    J Immunol; 1992 Sep; 149(6):2137-46. PubMed ID: 1517576
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Tumor-specific CTL kill murine renal cancer cells using both perforin and Fas ligand-mediated lysis in vitro, but cause tumor regression in vivo in the absence of perforin.
    Seki N; Brooks AD; Carter CR; Back TC; Parsoneault EM; Smyth MJ; Wiltrout RH; Sayers TJ
    J Immunol; 2002 Apr; 168(7):3484-92. PubMed ID: 11907109
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Peritoneal and splenic macrophage functions in the tumor-bearing host.
    Gardner TE; Naama H; Daly JM
    J Surg Res; 1995 Aug; 59(2):305-10. PubMed ID: 7637346
    [TBL] [Abstract][Full Text] [Related]  

  • 7. IFN-gamma differentially modulates the susceptibility of L1210 and P815 tumor targets for macrophage-mediated cytotoxicity. Role of macrophage-target interaction coupled to nitric oxide generation, but independent of tumor necrosis factor production.
    Leu RW; Leu NR; Shannon BJ; Fast DJ
    J Immunol; 1991 Sep; 147(6):1816-22. PubMed ID: 1909732
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Tumor-induced regulation of suppressor macrophage nitric oxide and TNF-alpha production. Role of tumor-derived IL-10, TGF-beta, and prostaglandin E2.
    Alleva DG; Burger CJ; Elgert KD
    J Immunol; 1994 Aug; 153(4):1674-86. PubMed ID: 8046239
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Treating tumor-bearing mice with low-dose gamma-interferon plus tumor necrosis factor alpha to diminish immune suppressive granulocyte-macrophage progenitor cells increases responsiveness to interleukin 2 immunotherapy.
    Pak AS; Ip G; Wright MA; Young MR
    Cancer Res; 1995 Feb; 55(4):885-90. PubMed ID: 7850804
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Intratumoral delivery of encapsulated IL-12, IL-18 and TNF-alpha in a model of metastatic breast cancer.
    Sabel MS; Su G; Griffith KA; Chang AE
    Breast Cancer Res Treat; 2010 Jul; 122(2):325-36. PubMed ID: 19802695
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The role of tumour necrosis factor-alpha in combination with interferon-gamma or interleukin-1 in the induction of immunosuppressive macrophages because of Mycobacterium avium complex infection.
    Tomioka H; Maw WW; Sato K; Saito H
    Immunology; 1996 May; 88(1):61-7. PubMed ID: 8707352
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Tumor modulation of autoreactivity: decreased macrophage and autoreactive T cell interactions.
    Yurochko AD; Burger CJ; Elgert KD
    Cell Immunol; 1990 Apr; 127(1):105-19. PubMed ID: 2138515
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Role of effector cell-derived IL-4, IL-5, and perforin in early and late stages of type 2 CD8 effector cell-mediated tumor rejection.
    Dobrzanski MJ; Reome JB; Dutton RW
    J Immunol; 2001 Jul; 167(1):424-34. PubMed ID: 11418679
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Differential effects of interleukin-4 and interleukin-10 on nitric oxide production by murine macrophages.
    Nemoto Y; Otsuka T; Niiro H; Izuhara K; Yamaoka K; Nakashima H; Niho Y
    Inflamm Res; 1999 Dec; 48(12):643-50. PubMed ID: 10669116
    [TBL] [Abstract][Full Text] [Related]  

  • 15. TNF alpha, IL-1 and O2- release by macrophages do not correlate with the anti-mouse hepatitis virus 3 effect induced by interferon gamma.
    Lucchiari MA; Modolell M; Vassão RC; Pereira CA
    Microb Pathog; 1993 Dec; 15(6):447-54. PubMed ID: 8007817
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Fibrosarcoma-induced increase in macrophage tumor necrosis factor alpha synthesis suppresses T cell responses.
    Alleva DG; Askew D; Burger CJ; Elgert KD
    J Leukoc Biol; 1993 Aug; 54(2):152-60. PubMed ID: 8360594
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Enhanced dendritic cell maturation by TNF-alpha or cytidine-phosphate-guanosine DNA drives T cell activation in vitro and therapeutic anti-tumor immune responses in vivo.
    Brunner C; Seiderer J; Schlamp A; Bidlingmaier M; Eigler A; Haimerl W; Lehr HA; Krieg AM; Hartmann G; Endres S
    J Immunol; 2000 Dec; 165(11):6278-86. PubMed ID: 11086063
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Promotion of macrophage-stimulated autoreactive T cell proliferation by interleukin-10: counteraction of macrophage suppressor activity during tumor growth.
    Alleva DG; Elgert KD
    Immunobiology; 1995 Feb; 192(3-4):155-71. PubMed ID: 7782092
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cytokine interactions in experimental cutaneous leishmaniasis. II. Endogenous tumor necrosis factor-alpha production by macrophages is induced by the synergistic action of interferon (IFN)-gamma and interleukin (IL) 4 and accounts for the antiparasitic effect mediated by IFN-gamma and IL 4.
    Stenger S; Solbach W; Röllinghoff M; Bogdan C
    Eur J Immunol; 1991 Jul; 21(7):1669-75. PubMed ID: 1905642
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Immunostimulatory properties and enhanced TNF- alpha mediated cellular immunity for tumor therapy by C60(OH)20 nanoparticles.
    Liu Y; Jiao F; Qiu Y; Li W; Qu Y; Tian C; Li Y; Bai R; Lao F; Zhao Y; Chai Z; Chen C
    Nanotechnology; 2009 Oct; 20(41):415102. PubMed ID: 19755733
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.